对于预防中风和降低出血风险, WATCHMAN FLX设备与血液稀释剂相比没有劣势. WATCHMAN FLX device found non-inferior to blood thinners for stroke prevention with lower bleeding risks.

冠军AF试验发现WATCHMAN FLX设备与血液稀释剂无差,用于预防心房患者的中风,并显著降低出血风险. The CHAMPION-AF trial found the WATCHMAN FLX device is non-inferior to blood thinners for stroke prevention in atrial fibrillation patients, with significantly lower bleeding risks. 这项涉及3000多名患者的研究支持该装置作为高危出血并发症者的一线治疗方案. The study, involving over 3,000 patients, supports the device as a potential first-line therapy for those at high risk for bleeding complications.